ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Orion and Bayer seek marketing clearance for darolutamide in Japan pharmaceutical-technology
March 06, 2019Orion and Bayer have submitted an application to the Japanese Ministry of Health, Labor and Welfare (MHLW) seeking marketing authorisation for darolutamide to be applied in the treatment castration-resistant prostate cancer (CRPC).
Pharma Sources Insight January 2025
